NCT07755332

Brief Summary

The aim of this study was to examine the relationship between central sensitization and resting RMSSD (Root Mean Square of Successive Differences) in individuals exhibiting prolonged sitting behavior, controlling for potential confounding factors such as age, gender, and body mass index; and to evaluate whether participants, grouped according to sitting durations, differed in terms of RMSSD, central sensitization, balance, and executive cognitive function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 5, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 10, 2026

Completed
Last Updated

August 10, 2026

Status Verified

August 1, 2026

Enrollment Period

3 months

First QC Date

August 5, 2026

Last Update Submit

August 5, 2026

Conditions

Keywords

postural balanceexecutive functioncentral sensitization

Outcome Measures

Primary Outcomes (3)

  • Demographic Information Collection

    Demographic information of the participants was collected using a participant assessment form developed by the research team. The form collected information about age, height, weight, body mass index, gender, education level, and weekly sitting time.

    Baseline (Single Assessment)

  • Assessment of Central Sensitization

    Central sensitivity was assessed using the Central Sensitivity Inventory. The scale ranges from 0 to 100, with higher scores indicating more severe symptoms.

    Baseline (Single Assessment)

  • Assessment of Heart Rate Variability

    Heart rate variability measurements were recorded at rest for 5 minutes using a Polar H10 device, in accordance with the recommendations of the European Society of Cardiology. The device was secured to the lower sternal notch with a belt. The RMSSD (Root Mean Square of Successive Differences, ms) parameter was used as an indicator of vagal activity.

    Baseline (Single Assessment)

Secondary Outcomes (2)

  • Assessment of Balance

    Baseline (Single Assessment)

  • Assessment of cognitive/executive function

    Baseline (Single Assessment)

Study Arms (1)

Healthy participants

Individuals who were between the ages of 18-45, had at least 30 hours of sitting time per week, agreed to participate voluntarily, and met the inclusion criteria participated.

Other: No intervention

Interventions

No intervention

Healthy participants

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population consisted of healthy young adults aged 18-45 years who spent at least 30 hours sitting per week.

You may qualify if:

  • Age range: Between 18 and 45 years of age.
  • Sitting time: Having at least 30 hours of sitting time per week.
  • Voluntary participation: Voluntarily agreeing to participate in the study.
  • Cognitive and sensory capacity: Having the cognitive, auditory, and visual capacity to understand the study procedures and perform the tasks.
  • Physical fitness: Not having any physical condition that would prevent the use of the HRV measuring device.

You may not qualify if:

  • Having any cardiovascular, neurological, or systemic disease that interferes with physical activity,
  • Using medications that may affect the autonomic nervous system within the last month,
  • Having a history of cognitive impairment,
  • Having engaged in strenuous exercise or had a febrile illness within the last 24 hours,
  • Having a clinically diagnosed central sensitization syndrome,
  • Being pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Demiroglu Bilim University

Istanbul, Silivri, 34570, Turkey (Türkiye)

Location

Study Officials

  • Selin Akil Agdere, Asst. Prof.

    Istanbul Demiroglu Bilim University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Prof.

Study Record Dates

First Submitted

August 5, 2026

First Posted

August 10, 2026

Study Start

January 1, 2026

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

August 10, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to confidentiality agreements and ethical restrictions.

Locations